
The Largest, Most Active Patient Communities
Activate highly engaged patients both in-community and across other channels for precise reach at unprecedented scale.
Reach opted-in patients with chronic and rare conditions
MyHealthTeam offers 30M visitors across 60+ communities in over 15 therapeutic areas a safe space to connect and get valuable, medically approved information when they need it.
Don’t see a community for your treatment’s condition?
We’ve partnered with more than 40 leading manufacturers to launch new communities, including Spanish language.
“MyHealthTeam exposes a more unique, highly qualified audience with the best targeting of all publishers.”
Veeva Crossix Net Impact Analysis
By joining MyHealthTeam’s highly engaged communities with Swoop’s precise reach at scale, healthcare marketers can build a powerful moat around their brands through patient-first and privacy-compliant omnichannel strategies.
Enhanced Patient Activation
Reach patients in communities and off-platform across our leading omnichannel partner and publisher network.
Community Audiences for TV
Create segments based on MyHealthTeam’s highly engaged audiences to target patients at scale on TV.
Predictive Audience Building
Engage patients at pivotal moments in their health journey both in-community and across all other channels.
Coordinated HCP Engagement
Activate consistent cross-channel messaging by connecting community members to their HCPs.
Proximity to patient, power in connection
MyHealthTeam is a leader in building trusted, condition-specific communities that empower patients and caregivers to see around corners of their health journey.

Media and Advertising
Improve your targeted advertising based on patient diagnosis, context, or topic with 4x better audience quality than endemic websites through zero-party data.

Patient Education
Empower patients to take action through branded or unbranded articles, videos, virtual experiences, events, and resource centers that drive engagement.

Clinical Trial Recruitment
Surface your trial to those most likely to pass screening based on diagnosis, treatments, and location, leading to higher randomization rates in half the time.
Research and Insights
Understand the real world patient experience through publishable surveys, social listening, and rapid insights that uncover unmet needs.
Community Launch
Partner with us to launch a new community where patients can access medically approved content and connect with others.
Not all data is created equal
MyHealthTeam data is zero-party, meaning it is voluntarily and explicitly shared by consumers who expect it to be used for their benefit in a privacy-compliant manner. This represents a game-changer for pharmaceutical advertising.
Uncover unique patient insights
MyHealthTeam research has been featured at more than 25 leading medical conferences covering health equity, treatment satisfaction, disease burden, and more.
MyHealthTeam
Understanding the Debilitating Nature of Narcolepsy in Patients’ Own Words: A Social Listening Analysis
Background Narcolepsy is a rare, chronic hypersomnolence disorder characterized by debilitating symptoms, including excessive daytime sleepiness (EDS), cataplexy, and disrupted nighttime sleep. Symptoms most typically appear during adolescence2; however, previous reports suggest that diagnosis can be complicated by lack of symptom recognition or misdiagnoses and may be delayed by >10 years. Real-world information and experiences […]
MyHealthTeam
Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters
Objective To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy. Background Challenges swallowing oral medications among children have been shown to affect adherence to treatment. This survey is of critical importance for the practicing neurologist, as it addresses issues related to medication formulation availability […]
MyHealthTeam
Patient Reported Attitudes Towards Multiple Sclerosis Treatment
Background Obstacles exist for getting patients on disease modifying treatments (DMTs) to slow progression. Understanding patient concerns can enable neurologists to help patients overcome barriers. Objective Research was undertaken to better understand awareness, usage, and attitudes towards DMTs.
Interested in conducting your own research?
From rapidly deployed surveys to social listening and deep insights, we help brands better understand their patients.
Customer Testimonials
Resources
MyHealthTeam
Better Together: Swoop and MyHealthTeam Overview
Combining the power of the largest provider of programmatic health audiences with the largest U.S. patient communities to deliver unparalleled scale and patient engagement.
DTC Marketing
The Rare Disease Marketing Guide: 5 Strategies Every Pharma Marketer Needs To Know for Patient Engagement
R&D in rare diseases has skyrocketed. Thirty percent of today’s R&D pipeline is in rare diseases, and 40 percent of overall pipeline growth since 2013 is due to rare diseases.
MyHealthTeam
Swoop Expands Patient-Centric Engagement with Acquisition of MyHealthTeam, a Leading Opted-In Patient Community in the U.S.
Swoop announces its acquisition of MyHealthTeam, the creator of one of the largest and most highly engaged opted-in patient social networks in the U.S.
